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ABSTRACT: 
Simian immunodeficiency virus (SIV) infection of rhesus macaques serves as a model of 
human immunodeficiency virus type 1 (HIV-1) infection in humans. It is well established that 
HIV-1 primarily infects CD4+ T cells, but this has not been well studied for SIV. Understanding 
the cells that can support viral replication is important for understanding where HIV-1 and SIV 
replicate during untreated infection, the cells that may harbor viral reservoirs throughout 
antiretroviral therapy (ART), and the cells that should be the target of curative strategies. Current 
methods for determining the entry phenotype of HIV-1 utilize Affinofile cells (cells with drug-
inducible human CCR5 and CD4) to measure HIV-1’s ability to enter cells expressing a low 
density of CD4; which has been shown to be a defining feature of viruses adapted to replication in 
macrophages (i.e. macrophage-tropic viruses). However, the ability to assess the cellular tropism 
of SIV has been limited by a lack of such tools. Consequently, an SIV/macaque model system that 
recapitulates this important part of HIV-1-human interaction is of importance. In conjunction with 
the development of a cell line expressing rhesus CD4 and rhesus CCR5 for improved, future 
phenotyping studies, I examined whether 21 SIV envelope proteins were macrophage-tropic based 
on their ability to efficiently enter Affinofiles expressing a low density of CD4. After cloning and 
phenotyping assays, viral entry phenotypes were measured and showed the presence of low CD4-
using, or macrophage-tropic, virus at all time points measured in both the CSF and plasma 
compartments over the course of infection. Because the evolution of macrophage tropism was 
undetectable, this may be a typical phenotype of SIV throughout pathogenesis. 
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INTRODUCTION: 
Human immunodeficiency virus type 1 (HIV-1) is a progressive disease characterized by 
the slow depletion of CD4+ T cells and fatal immune dysfunction if left untreated (1, 2). HIV-1 
enters host cells by the binding of the glycoprotein Envelope (Env) to the CD4 receptor and then 
either the CCR5 or CXCR4 coreceptor to mediate fusion of the virus and host cell membrane (1, 
2). Most transmitted HIV-1 viruses are adapted to entering cells expressing the CCR5 coreceptor 
and a high density of CD4, similar to the levels expressed on CD4+ T cells, and much higher than 
the levels expressed on monocytes or macrophages (3, 4). As pathogenesis progresses, decreasing 
levels of T cells, expressing high densities of CD4, may select for viruses capable of infecting cells 
expressing a low density of CD4 such as macrophages; which may explain why macrophage-tropic 
HIV-1 is often found in the central nervous system (CNS) late in disease (3-7). 
Throughout pathogenesis, some patients with HIV-1 are also known to have distinct viral 
lineages evolve in the genital tract, cerebrospinal fluid (CSF), and the brain (4). This phenomenon, 
called compartmentalization, signifies non-mixing populations of viruses replicating and evolving 
in different anatomical regions, and is a relevant indicator of possible macrophage-tropic 
evolution. Thus, it is an important area of study for understanding HIV pathogenesis as well as 
what cells may function as latent reservoirs (4). Current literature debates what types of cells are 
capable of harboring latent virus in the CNS (5). By researching how this phenomenon is 
characterized in different tissues, cure strategies could be tailored to eliminate latent HIV-1 
reservoirs. However, accessing the data necessary to successfully study patients 
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with compartmentalization and macrophage-tropic evolution comes with barriers such as invasive 
sampling techniques. Thus, a reproducible model system capable of generating meaningful data is 
scientifically important. 
Currently, research shows many of simian immunodeficiency virus’ (SIV) pathogenetic 
characteristics closely parallel that of HIV-1 (8-10). For instance, some samples of SIV in rhesus 
macaques can utilize CD4+ T cells to infect and proliferate (8). Furthermore, SIV has been shown 
to use CCR5 and various CD4 densities depending on cell and tissue type (8, 9). Additionally, 
previous studies have found evidence of compartmentalization via CNS isolates containing distinct 
evolving viral lineages capable of infecting macrophages (10-14). Thus, SIV infection of rhesus 
macaques represents a possible model system for studying compartmentalization and macrophage-
tropic evolution. 
In this study we examined whether, like HIV-1, the majority of SIV variants are adapted 
to entering CD4+ T cells, but occasionally adapt to entering macrophages in the CNS, or more 
broadly, if SIV is typically macrophage-tropic. In order to address these questions, 21 SIV 
envelope clones were generated from cerebrospinal fluid (CSF) and plasma samples longitudinally 
collected from four SIV-infected rhesus macaques. Pseudovirus (virus lacking a functional 
envelope capable of a single round of infection) was subsequently generated by co-transfecting 
SIV env genes with an HIV-1 subtype B backbone (4-6). Resultant viruses were then tested on 
Affinofile cells (cells with inducible human CD4 and human CCR5) induced to have high and low 
CD4 densities; a method previously shown as an accurate and reproducible way of identifying 
viruses that are macrophage-tropic based on their ability to enter cells expressing a low density of 
CD4 (15-19). SIV envelopes selected from the plasma and CSF from 
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multiple time points throughout the course of infection showed macrophage-tropic phenotypes, 
indicating no evidence for evolution of macrophage tropism in SIV and the possibility of persistent 
macrophage tropic viruses throughout pathogenesis. 
Along with this study, we endeavored to generate an inducible cell line better equipped to 
phenotype SIV. Currently, Affinofile cells allow researchers to phenotype HIV-1’s ability to enter 
cells expressing a low density of CD4 (i.e. macrophage tropism) or those with a high density of 
CD4 for entry (i.e. T cell tropic); however, a similar model system for assessing the cellular 
tropism of SIV does not exist (15-17). Thus, we attempted to generate a similar cell line that would 
express inducible rhesus CD4 and constitutively express rhesus CCR5 to assess the ability of our 
cloned SIV envs to efficiently enter cells expressing a low density of rhesus CD4. 
 
MATERIALS AND METHODS 
 
Rhesus macaque infection and collection of virus 
Four rhesus macaques were challenged intravenously with either the SIVsm swarm E660 
(monkey ID: 21783, 21602) or the SIVsm clone E543 (monkey ID: 21775, 21787) (23). The blood 
and CSF were longitudinally sampled every two weeks for the initial three months. Subsequent 
collection was conducted every four weeks to monitor later timepoints of pathogenesis (23). All 
macaques were humanely euthanized following indications of end-stage disease (23). Animal care 
was performed at Columbus, Ohio, Children's Research Institute with institution guidelines. 
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SIV Amplicon Cloning 
Previously isolated amplicons of the full SIV env gene were sequenced by Dr. Christa 
Sturdevant from four different SIV-infected rhesus macaques (monkey ID: 21783, 21787, 21775, 
and 21602), and were cloned using our previously described method (22). First, Phusion Hot-Start 
High-Fidelity DNA Polymerase PCR was used to amplify the DNA. Second, the Phusion PCR 
products were gel extracted from a 1% agarose gel. The desired 3kb bands were visualized with a 
blue box reader using the QIAquick Gel Extraction Kit (Qiagen) with the following modifications: 
wash buffer was allowed to incubate for 5 minutes, and during the elution step, 50 µL of dH2O 
was applied, incubated, eluted, and then the steps were repeated. Final, purified DNA was then 
stored at -20 °C (22). 
Following this, a TOPO cloning/ligation reaction with a pcDNA 3.1 Directional TOPO 
Expression Kit (Invitrogen) was used to clone the DNA of interest. Envelope DNA, salt, and TOPO 
vector were mixed and incubated at room temperature for 30 minutes. Following this, the reaction 
mixture was added to 50 µL of Stbl2 cells (ThermoFisher), incubated on ice for 30 minutes, heat 
shocked at 42 °C for 25 seconds, and then incubated on ice for 2 minutes. Then, 450 µL of SOC 
media was added to the resulting mixture and incubated at 30 °C for 90 minutes. The bacteria was 
spun down to maximize concentration and then plated on carbenicillin treated agar plates at 50 
µg/mL. Following an overnight incubation at 30 °C, individual colonies were picked and placed 
in 100 µL of LB-Carb media with carbenicillin at 2 µg/mL on a 96 well plate. These incubated 
overnight at 30 °C. Finally, a colony PCR reaction was performed using SIV primers. Then, 1 µL 
of bacteria was added to 12 µL of master mix. The primers for the colony 
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PCR were 5’-CACCTGGAGACACCCTTGAAGGAGC3’ and 5’ 
GAGACATGTCTATTGCCAATTTG-3’ to amplify env. After 40 cycles, the PCR product was 
visualized on a gel and the band of interest was identified. The bacteria in the matching well of the 
24 well plate was then grown in LB-Carb media overnight, and a Qiagen Miniprep kit was used 
for DNA extraction. 
 
Cell Culture 
293T cells were cultured in Dulbecco’s Modified Eagle Medium (DMEM) with 4.5 g/liter 
glucose (Cellgro) and 10% fetal bovine serum (FBS), 100 U/mL penicillin, and 100 µg/mL 
streptomycin (Sigma) (20). Affinofile cells were cultured in DMEM with 10% dialyzed Fetal 
Bovine Serum (FBS) (12–14 kD dialyzed; Atlanta Biologicals) and Blasticidin 50 µg/ml 
(Invitrogen) referenced as Affinofile media. Cells were maintained at 37 °C and passaged every 
2-3 days (21). 
 
Pseudotyping Virus 
2 mL of 293T cells was added to six well plates at a density of 2.5 x 105 cells/mL the day 
prior to transfection. Following this, 0.81 µg of cloned SIV env vector was aliquoted. A total of 21 
distinct env vectors were used. 64.8 µL of Serum Free Media and 4.9 µL of FuGENE 6 (Promega) 
were added to each aliquot of env vector and vortexed. 70.5 µL of the transfection mix was added 
to the env vector, vortexed and incubated for 30 minutes. The resulting mixture was added 
dropwise to the cells and swirled. Each env vector was co-transfected with and HIV-1 subtype B 
backbone (pNL4-3.LucR-E- obtained from NIH AIDS Research). Two positive 
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controls with known HIV env sequences and entry phenotypes were tested as well as two negative 
controls lacking an env sequence. Following two days of incubation, the resultant virus was sterile 
filtered and stored at -80 °C. 
 
Titering Virus 
Following this, the linear range of infectivity for each virus was assessed by pretitering 
virus on Affinofile cells with maximum CCR5 and CD4 expression (5, 21). This step controlled 
for background noise in the luciferase assay, and ensured that the virus was diluted to the desired 
Relative Light Unit (RLU) readout (5, 21). Affinofile cells were seeded into the inner 60 wells of 
96 well plates. All outer wells of each plate were filled with 100 µL of PBS to ensure proper 
readings from the luminometer. 50 µL of Poly-L-Lysine was added to sterile black plates and 
incubated at 37 °C for 20 minutes (Sigma). Poly-L-Lysine was removed, and harvested cells were 
counted and diluted to a concentration of 1.8 x 105cells/ mL. Then 100 µL of cells per well were 
plated and incubated at 37 °C. The next day Doxycycline (Sigma 45-0478) (Doxycycline D9891) 
was diluted to create a 6 ng/mL final concentration to induce maximum CD4 expression. 
Ponasterone A (Invitrogen 45-0478) was also diluted to create a 5 µM final concentration for 
maximum CCR5 expression. To add drug to the cells for induction, 50 µL of media was removed 
from each well. 50 µL of warmed media, PonA, and doxycycline were added to each well. Proper 
induction of CD4 and CCR5 was measured using flow cytometry. The next morning, induction 
media was removed from the wells and immediately replaced with 50 µL of Affinofile media. The 
volumes 1, 2, 4, 6, 12, and 25 µL of virus were added to different wells to establish a titering curve, 
and plates were centrifuged at 2000 rpm for 2 hours at 37 °C. Two days 
9 
later, infectivity was measured. First, media was removed from the wells and washed twice with 
PBS. Then, 50 µL of lysis buffer was added and incubated at room temperature for 15 minutes. 
The solution was frozen overnight at -80 °C (5, 6). 
 
Data Collection 
The thawed 96 well plates were examined using a firefly luciferase assay under a 
luminometer (Promega) to discern the level of infectivity (5, 6). Readings in RLUs were quantified 
and plotted to determine an infectivity curve. Virus was diluted in Affinofile media so that 1 mL 
= 30 million RLUs when titered on Affinofiles (5, 6). 
 
High Low Assay 
The same method as described in the titering section above was utilized for the cells; 
however, during the induction stage, wells were drugged in triplicate with 5 µM concentration of 
Pon A, along with 3 wells receiving 5 µM concentration of Pon A and 6 ng/mL concentration of 
Doxycycline (5, 6). The former induces cells with maximum CCR5 and low CD4, while the latter 
induces cells with maximum CCR5 and high CD4. The cells were incubated at 37 °C for 18-24 
hours. 50 µL of diluted virus was added to each well for infection and centrifuged at 2000 rpm for 
2 hours. Following a 48 hour incubation, the cells were lysed and frozen using the lysis protocol 
from Titering Virus, and treated with a luciferase assay (5, 6). 
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Calculating High Low Results 
Data corresponding to infectivity from the luciferase assay was gathered and used to 
calculate percent infectivity for both low and high CD4 wells. This data was then compared to 
assess the viruses’ ability to infect at low vs. high CD4 and plotted on a bar graph (5). 
 
293T Co-Transfection with Puromycin selectable marker and SIV CCR5 Protocol 
One day before transfection 7 x 105 293T cells were plated on a 10 cm dish in 10 mL of 
culture media. Three treatment plates were created and one negative control. The following day, 
51 µL of room temperature FuGENE 6 was added to 486 µL of DMEM. Following tapping and 
incubation of this mixture for 5 mins at room temperature, 5 µg of PurVector (Clontech) and SIV 
CCR5 plasmid (provided by Dr. Adrienne Swanstrom) were added and incubated for 30 minutes. 
Two other mixes were created, one with 0.5 µg of puro-Vector, and one with 50 ng puro-Vector. 
Following the incubation period, the full mixture of FuGENE, media, and DNA were added 
dropwise to the cells and swirled. The cells were then incubated for 72 hours; after this the media 
was changed, and drug selection began with 2 µg/mL puromycin being added to all plates but the 
negative control. The media was changed every 2-3 days and cells were examined daily to monitor 
colonies expressing non-transient plasmid expression. Upon colony formation, individual colonies 
were picked under the microscope in 10 µL of media, aliquoted into a 96 well plate, and expanded 
into 75 mL flasks. Rhesus CCR5 expression was subsequently verified using flow cytometry. 
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Transfection with Inducible rh-CD4 Vector and Tet-On Repressor 
Previously transfected cells with CCR5 were transfected using the same method above 
except with a Tet-On repressor and PO/6 vector containing a sequenced rhesus CD4 gene isolated 
from restriction digests (Thermo-Fisher K102001). Single cell colonies were selected following 
selection with Blasticidin and Zeocin and are awaiting flow cytometry confirmation (Thermo-
Fisher K102001). 
 
RESULTS: 
 
Phylogenetic trees generated from envsequences show evidence of compartmentalization. 
SIV is a salient model system for HIV-1 pathogenesis in many ways due to genetic and 
pathogenetic similarities. To assess SIV’s ability to model HIV-1’s evolution of viral entry 
phenotypes, envelope sequences generated from blood and CSF samples were compiled for 
monkeys 21783, 21787, 21775 and 21602 by Dr. Christa Sturdevant and incorporated into 
phylogenetic trees represented in Figures 1-4. Distinct viral lineages, or compartments, were 
evident in the CSF for macaques 21783, 21787, and 21775, indicating evidence of 
compartmentalization for 75% of monkeys sampled. It has been  previously demonstrated that the 
evolution of macrophage tropism in the CNS produces compartmentalized lineages (6-8). Because 
the frequency of compartmentalization detected in these macaques via phylogenetic analysis was 
high, and represents an indicator for the possibility of macrophage-tropic evolution, viral 
phenotyping was conducted. 
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Pseudotyped virus with SIV env in HIV-1 subtype B backbone shows M-tropic entry 
phenotype for both plasma and CSF. 
To assess if viral tropism shifts over time and in different compartments within SIV as a 
model system, viral entry phenotyping assays of pseudotyped virus with SIV Envelope proteins 
were conducted. We selected env sequences from macaques 21783, 21787, 21775, and 21602 to 
create a representative population for assessing change in tropism over time and compartment. 
For the viruses derived from the monkey 21783, samples from both the CSF and plasma 
showed an M-tropic phenotype (Figure 7). Furthermore, no significant increase in macrophage 
tropism was found from viruses expressing Envelope proteins isolated from later time points 
compared to earlier time points. Viruses isolated from the monkey 21787, sampled from both the 
CSF and plasma, also showed an M-tropic phenotype (Figure 8). Viruses sampled from the 
monkey 21775 from both the CSF and plasma showed an M-tropic phenotype (Figure 9). 
Similarly, viruses derived from the monkey 21602, from both the CSF and plasma showed an M-
tropic phenotype (Figure 10). Along with this, no significant increase in macrophage tropism was 
found in Envs isolated from later time points for any sampled virus. Together these results indicate 
that HIV-1 subtype B pseudotyped viruses with an SIV derived env vector show M-tropic entry 
phenotypes regardless of the compartment or time point in all tested samples. 
 
New cell line expresses constitutive rhesus CCR5 
Our lab has been working on generating a cell line capable of better reproducing in vivo 
interactions of SIV within rhesus macaques through the use of a cell line featuring inducible rhesus 
CD4 and constitutive rhesus CCR5. Currently, flow cytometry data shown in Figure 11 indicates 
successful constitutive expression of rhesus CCR5 at levels comparable to Affinofile cells. Due to 
the nature of this phenotyping assay, where CCR5 is expressed at high levels for  
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both experimental conditions, CCR5 was not made inducible. A rhesus CD4 gene was transfected 
utilizing a Tet-On system, and cells are currently being selected for single cell cloning and 
expansion. 
 
DISCUSSION: 
 
Overview 
SIV is one of the closest genetic relatives of HIV-1, and consequently, shares numerous 
similarities in structure and pathogenesis (15). In order to assess the validity of SIV as a possible 
model system for the evolution of macrophage-tropic HIV-1, 21 envelope genes were successfully 
cloned, and used to generate pseudovirus. These were tested for macrophage tropism based on 
their ability to infect Affinofile cells expressing a low density of CD4 and a high density of CCR5. 
The env genes were cloned from CSF and plasma isolates longitudinally sampled from four SIV-
infected rhesus macaques. 
 
Phylogenetic Analysis 
With the phylogenies Dr. Sturdevant generated, it was clear that 3 of the 4 macaques had 
compartmentalized lineages in their CSF (Figures 1-3). In HIV-1, such lineages are produced by 
independent viral replication in the CNS with little to no migration of viral variants from the 
plasma into the CNS (3-6). In humans, macrophage-tropic HIV-1 is also often observed in lineages 
that are compartmentalized in the CSF (5, 6). Thus, detection of compartmentalized lineages in the 
CSF is a possible indicator of macrophage-tropic HIV-1 in the CNS. This finding subsequently 
brought into question whether compartmentalized lineages in the CNS of SIV-infected macaques 
are an indication that macrophage-tropic variants have evolved in that compartment. 
14 
Cloning and High Low Assay Analysis 
To analyze this question, SIV envelope sequences were selected from Dr. Sturdevant’s 
phylogenetic trees to assess the changes in entry phenotype over time and in each compartment. 
Following cloning and transfection of env vectors with an HIV-1 subtype B backbone, a viral entry 
phenotyping assay was conducted on Affinofile cells (Figures 5, 6). Results indicated that 
all SIV envelope sequences conferred a macrophage-tropic entry phenotype for all timepoints and 
compartments (Figures 7-10). Specifically, all entry phenotypes exhibited an ability to infect 
Affinofiles with low density CD4 at 10-70% as well as Affinofiles expressing high density CD4. 
Compared to the macrophage tropic control 4059C, these values were in line with previously 
established levels of infectivity at low CD4 for M-tropic viruses. Furthermore, there was no 
discernible difference between levels of macrophage-tropic phenotypes over time or samples from 
the blood or CSF. In HIV-1, macrophage-tropic viruses have only been found in the CSF during 
chronic infection. Because Figures 7-10 show no increase or difference between entry phenotypes 
for SIV sampled from the CSF compared to the blood, and no difference regardless of time point, 
the results do not show evidence for the evolution of macrophage tropism within the CNS of rhesus 
macaques.  
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Factors influencing SIV as a model system. 
 
1. Affinofile cells express human CD4 receptors and human CCR5 coreceptors on the 
surface of the cell. CD4 and CCR5 molecules in rhesus macaques differ from human CD4 and 
CCR5 at multiple residues affecting conformation (8-10). Therefore, Affinofile cells may not be 
able to accurately measure the phenotype of SIV Envelopes to recapitulate interactions with 
rhesus cells in vivo. This could occur if SIV uses human CD4 efficiently and therefore infects 
Affinofile cells well regardless of CD4 density. 
2. Similarly, although the env gene alone confers viral entry tropism (which can be used to 
measure SIV’s entry phenotype), the pseudotyped virus contained an HIV-1 subtype B backbone, 
which is genetically distinct in multiple ways from that of SIV (1-4). Consequently, it is possible 
that the thermodynamics of viral fusion and entry are altered in meaningful ways; thus, the 
phenotype measured could represent something other than the in vivo interactions of SIV with 
rhesus cells. 
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3. The idea of species to species transmission must also be addressed as a source of error. 
When viruses jump from species to species, the characteristics that evolved within the original 
host frequently have different manifestations within a new host. In many cases, when this jump 
occurs, the new host lacks receptors for the virus and infection is not established. Conversely, 
sometimes when certain viruses enter a new host, more severe infections are possible. This mode 
of transmission is salient for consideration in this experiment, because viruses were isolated from 
African sooty mangabeys expressing high viral loads that were relatively asymptomatic, and 
subsequently used to infect Asian rhesus macaque monkeys; who are known to establish 
significantly higher viral loads than humans and develop acquired immunodeficiency syndrome 
(AIDS) more rapidly (23-26). Rhesus macaques are an important model system for HIV-1 due to 
their susceptibility to infection from SIV and subsequent pathogenesis resulting in 
immunodeficiency (23). That said, the higher viral loads present within both sooty mangabeys and 
rhesus macaques could potentially affect results. The different evolutionary paths of viruses taken 
in each animal, due to biological differences in respective species, could affect experimental 
assays attempting to glean information on HIV-1 (23, 24). Specifically, the ability for these 
animals’ immune responses to function with high SIV viral loads raises the possibility of viruses 
that normally would not be seen in humans persisting within sooty mangabeys and rhesus 
macaques. This could help to explain results of macrophage-tropic phenotypes present from early 
time points. Increased viral loads present in sooty mangabeys and rhesus macaques could have 
precluded their immune systems from eliminating viruses expressing the macrophage-tropic 
phenotype from initial infection. If this were the case, that could explain the possibility of 
persistent macrophage-tropic phenotypes determined by the Affinofile assay (Figures 7-10). 
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4. Finally, the density of CD4 on rhesus macaque cells is not known. If rhesus macaque 
cells express lower densities of CD4, this could help to explain the result of consistent macrophage-
tropic phenotypes. The definition of a cell with low density CD4 for a human could be different, 
and therefore the assay would not have detected a marked difference if the Affinofiles with low 
density CD4 were higher than CD4+ cells in rhesus macaques. The net result would be the ability 
to infect Affinofiles at both high and low CD4 densities, because both conditions were sufficiently 
high density when compared to rhesus macaque cells. 
 
Future directions of a rhesus macaque cell line and SIV backbone. 
In order to address these caveats, our lab has been working on generating a cell line capable 
of better reproducing in vivo interactions of SIV within rhesus macaques through the use of a cell 
line featuring inducible rhesus CD4 and constitutive rhesus CCR5. Along with this, we are 
working with collaborators to obtain an SIV backbone for pseudotyping to control for possible 
effects due to differences between HIV-1 and SIV backbones throughout viral entry phenotyping 
assays. Finally, we are also working with collaborators to determine the density of CD4 on 
representative CD4+ cells within the plasma and CSF of rhesus macaques to address possible 
constraints to using phenotyping assays with Affinofiles. 
In summary, these results point to the possibility of the presence of macrophage-tropic SIV 
viruses throughout infection and regardless of compartment. Along with this, Dr. Christa 
Sturdevant’s phylogenies provide evidence for compartmentalization within rhesus macaques, and 
therefore viral replication/evolution occurred in the CNS. The former results are in line with 
previous phenotyping assays of SIV from vaginal samples showing the ability to infect cells at 
both high and low CD4 densities (M-tropic) (30). The latter results also recapitulate current data  
18 
showing that rhesus macaques could be a viable model system to examine other modalities of 
compartmentalization in the future (10-14). Together, these results open the door to new studies 
on compartmentalization and macrophage-tropic evolution to determine what types of cells HIV-
1 infects within the CNS. In turn, future analysis of these topics could inform future, novel curative 
strategies to combat latent HIV-1 reservoirs within the CNS
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Figure 1. Rhesus Macaque Viral Phylogeny 21783 
 
This viral phylogeny created by Dr. Christa Sturdevant was from a rhesus macaque (ID 21783) 
infected with the SIV swarm SIV E660. Amplicons were expanded, cloned, and co-transfected 
with an HIV-1 subtype B backbone. Blue circles at nodes highlight CSF compartments. Samples 
denoted as pink triangles were derived from the blood four weeks post infection. Samples in red 
triangles were derived from the blood forty weeks post infection. Samples in light blue circles 
were derived from the CSF four weeks post infection. Samples shown as dark blue circles were 
derived from the CSF forty weeks post infection. Samples highlighted with a green shape were 
successfully cloned and used for entry phenotyping. 
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Figure 2. Rhesus Macaque Viral Phylogeny 21787 
 
This viral phylogeny made by Dr. Christa Sturdevant was generated from a rhesus macaque (ID 
21787) infected with the clone SIV E543. Amplicons were expanded, cloned, and co-transfected 
with an HIV-1 subtype B backbone. The large blue circle indicates a CSF compartment. Samples 
shown as pink triangles were derived from the blood six weeks post infection. Samples in red 
triangles were derived from the blood forty weeks post infection. Samples in blue circles were 
sampled from the CSF forty weeks post infection. Samples highlighted with a green shape were 
successfully cloned and used for entry phenotyping. 
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Figure 3. Rhesus Macaque Viral Phylogeny 21775  
This viral phylogeny made by Dr. Christa Sturdevant was generated from a rhesus macaque (ID 
21787) infected with SIV E543. Amplicons were expanded, cloned, and co-transfected with an 
HIV-1 subtype B backbone. The large blue circle indicates a CSF compartment. Samples shown 
as pink triangles were derived from the blood four weeks post infection. Samples in red triangles 
were derived from the blood forty weeks post infection. Samples shown as light blue circles were 
sampled from the CSF four weeks post infection. Samples in blue circles were sampled from the 
CSF forty weeks post infection. Samples highlighted with a green shape were successfully cloned 
and used for entry phenotyping. 
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Figure 4. Rhesus Macaque Viral Phylogeny 21602 
 
This viral phylogeny generated by Dr. Christa Sturdevant was from a rhesus macaque (ID 21602) 
infected with the SIV swarm E660. Amplicons were expanded, cloned, and co-transfected with an 
HIV-1 subtype B backbone on Affinofile cells. Samples shown as pink triangles were derived from 
the blood two weeks post infection. Samples shown as magenta triangles were derived from the 
blood six weeks post infection. Samples displayed as light blue circles were derived from the CSF 
two weeks post infection. Samples shown as blue circles were derived from the CSF six weeks 
post infection. Samples shown as dark blue circles were derived from the CSF eight weeks post 
infection. Samples highlighted with a green shape were successfully cloned and used for entry 
phenotyping. 
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Figure 5. CD4 Density on cells susceptible to HIV entry and infectivity curves vs. CD4 
density  
Infectivity at high CD4 density is comparable in both macrophage tropic (M-tropic) and T-cell 
tropic variants (T-tropic), while infectivity at low CD4 density is typically higher for macrophage 
tropic variants (6). Ba-L, 4059 C, and 5002 C are previously tested M-tropic controls (6). JR-CSF, 
4059P, and 5002P are T-tropic control viruses shown to infect appreciably only at high CD4 
densities (6). The left most portion of the figure indicates CD4 density for various cell types. The 
middle panel indicates infectivity curves of viruses depending on CD4 density. 
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Figure 6. Diagram of Pseudotyping Virus and High Low Assay 
 
Part A of the diagram generally outlines the creation of pseudotyped virus by co-transfecting 293T 
cells with an HIV-1 backbone and env vector (5, 6). Part B of the diagram shows induction of high 
CD4 and low CD4 Affinofile cells, subsequent pseudotyped viral infection, and the firefly 
luciferase reporting system; whose fluorescence is used to quantify infectivity (5, 6). 
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Figure 7. High Low Assay Percent Infectivity for 21783 
 
The following graph depicts the percent infectivity at low CD4 compared to high CD4 for the 
monkey 21783. The M-tropic control is indicated in black (4059 C). The T-tropic controls is 
indicated in grey (4059 P). Red and pink bars represent samples from the blood and blue bars the 
CSF. The specific amplicons tested are visible on Figure 1,and include: plasma samples from 
week 4 amplicon 10 (pink), week 40 amplicons 12 and 8 (red), CSF samples week 4 amplicon 19 
(light blue), and week 40 amplicons 4 and 3 (dark blue). All exhibit infectivity at low CD4. Error 
bars are present on samples ran with multiple clones of the same virus. 
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Figure 8.High-Low Assay Results for Macaque 21787 
The following graph depicts the percent infectivity at low CD4 compared to high CD4 for the 
monkey 21787. The M-tropic control is indicated in black (4059 C). The T-tropic controls is 
indicated in grey (4059 P). Red bars represent samples from the blood and blue bars the CSF. The 
specific amplicons tested are visible on Figure 2,and include: plasma week forty amplicons 18 
and 4 (red), along with CSF week 40 amplicons 8 and 7 (blue). Error bars are present on samples 
ran with multiple clones of the same virus. 
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Figure 9. High-Low Assay Results for Macaque 21775  
The following graph depicts the percent infectivity at low CD4 compared to high CD4 for the 
monkey 21775. M-tropic controls are indicated in black as 4059 C. T-tropic controls are indicated 
in black as 4059 P. Red bars represent samples from the blood and blue bars the CSF. The specific 
amplicons tested are visible on Figure 3,and include: plasma week four samples 9 and 10 (pink), 
plasma week forty amplicon 6 (red), along with CSF week four amplicons 6 and 1 (blue). Error 
bars are present on samples ran with multiple clones of the same virus. 
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Figure 10.High-Low Assay Results for Macaque 21602 
The following graph depicts the percent infectivity at low CD4 compared to high CD4 for the 
monkey 21602. M-tropic controls are indicated in black as 4059 C. T-tropic controls are indicated 
in grey as 4059 P. Magenta bars represent samples from the blood and blue bars the CSF. The 
specific amplicons tested are visible on Figure 4, and include: plasma week 6 amplicon 45 
(magenta), along with CSF week 2 amplicons 5 (light blue), CSF week 6 amplicons 15 and 17 
(medium blue), CSF week 8 amplicons 7 and 2 (dark blue). Error bars are present on samples ran 
with multiple clones of the same virus. 
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Figure 11. Flow Cytometry Results for 293T Cells Transfected with rhCCR5  
Flow cytometry detection using PE indicated high levels of rhesus CCR5 expression on 293T cells 
co-transfected with rhesus CCR5 and a puromycin resistance plasmid. The red peak indicates 
stable expression of rhCCR5 established from single cell cloning on clone 3. The blue peak 
indicates stable expression of rhCCR5 established from single cell cloning on clone 7. The left 
black gate indicates the range of expression detected on untreated 293T cell negative controls. 
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